State of Wyoming Has $340,000 Stock Holdings in Embecta Corp. (NASDAQ:EMBC)

State of Wyoming raised its holdings in Embecta Corp. (NASDAQ:EMBC) by 51.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 16,479 shares of the company’s stock after acquiring an additional 5,625 shares during the quarter. State of Wyoming’s holdings in Embecta were worth $340,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Siemens Fonds Invest GmbH acquired a new stake in Embecta in the fourth quarter valued at approximately $77,000. ProShare Advisors LLC lifted its stake in shares of Embecta by 44.5% in the fourth quarter. ProShare Advisors LLC now owns 17,464 shares of the company’s stock worth $361,000 after buying an additional 5,376 shares during the last quarter. Meros Investment Management LP lifted its stake in shares of Embecta by 30.2% in the fourth quarter. Meros Investment Management LP now owns 247,312 shares of the company’s stock worth $5,107,000 after buying an additional 57,312 shares during the last quarter. Deutsche Bank AG boosted its holdings in shares of Embecta by 40.8% during the 4th quarter. Deutsche Bank AG now owns 56,110 shares of the company’s stock worth $1,159,000 after buying an additional 16,249 shares during the period. Finally, Deerfield Management Company L.P. Series C grew its stake in Embecta by 19.8% in the 4th quarter. Deerfield Management Company L.P. Series C now owns 3,270,535 shares of the company’s stock valued at $67,537,000 after buying an additional 540,192 shares during the last quarter. 93.83% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Mizuho initiated coverage on shares of Embecta in a research report on Thursday, April 10th. They set a “neutral” rating and a $15.00 target price for the company.

Embecta Stock Performance

Shares of NASDAQ:EMBC opened at $12.35 on Thursday. The company has a market cap of $721.77 million, a P/E ratio of 12.35, a P/E/G ratio of 0.78 and a beta of 1.24. The stock’s 50-day moving average is $12.25 and its 200-day moving average is $15.62. Embecta Corp. has a 52-week low of $10.83 and a 52-week high of $21.48.

Embecta (NASDAQ:EMBC) last issued its quarterly earnings results on Friday, May 9th. The company reported $0.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.66 by $0.04. Embecta had a negative return on equity of 19.22% and a net margin of 5.25%. The company had revenue of $259.00 million for the quarter, compared to the consensus estimate of $261.77 million. During the same period last year, the business posted $0.67 earnings per share. The firm’s revenue was down 9.8% compared to the same quarter last year. As a group, equities analysts predict that Embecta Corp. will post 2.85 EPS for the current year.

Embecta Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Investors of record on Wednesday, May 28th will be given a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 4.86%. The ex-dividend date is Wednesday, May 28th. Embecta’s dividend payout ratio (DPR) is currently 66.67%.

Embecta Company Profile

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.